Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
24
PSTV Quote, Financials, Valuation and Earnings
Last price:
$1.09
Seasonality move
:
5.93%
Day range:
$0.97 - $1.11
52-week range:
$0.93 - $2.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.19x
P/B ratio:
--
Volume:
49K
Avg. volume:
84K
1-year change:
-41.4%
Market cap:
$6.4M
Revenue:
--
EPS (TTM):
-$2.53
Earnings Data
Next earnings date for PSTV
--
Most recent earnings per share
-$0.37
Beat by $0.19
(Sep 30/2024)
Consensus Estimate
-$0.56
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PSTV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | $1.2M | -- | -- | -$0.51 | -- |
| 09/30/2024 | Q3 | $1.1M | -- | -$0.37 | -$0.56 | $0.19 |
| 06/30/2024 | Q2 | $1.1M | -- | -$0.71 | -$0.53 | -$0.18 |
| 03/31/2024 | Q1 | $1.7M | -- | -$0.75 | -$1.09 | $0.34 |
| 12/31/2023 | Q4 | $850.7K | -- | -$0.70 | -$1.17 | $0.47 |
| 09/30/2023 | Q3 | -- | -- | -$1.00 | -$1.18 | $0.18 |
| 06/30/2023 | Q2 | -- | -- | -$0.59 | -$2.03 | $1.44 |
| 03/31/2023 | Q1 | -- | -- | -$2.07 | -$2.20 | $0.13 |
| 12/31/2022 | Q4 | -- | -- | -$2.36 | -$2.20 | -$0.16 |
| 09/30/2022 | Q3 | -- | -- | -$2.85 | -$3.20 | $0.35 |
| 07/22/2022 | Q2 | -- | -- | -$3.56 | -$2.85 | -$0.71 |
| 04/22/2022 | Q1 | -- | -- | -$2.85 | -- | -- |
| 02/15/2022 | Q4 | -- | -- | -$4.05 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$4.20 | -- | -- |
| 07/22/2021 | Q2 | -- | -- | -$3.75 | -- | -- |
| 04/22/2021 | Q1 | -- | -- | -$4.95 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$10.95 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$5.85 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$6.75 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$4.20 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $3.42 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.45 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$310.05 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$133.80 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$113.08 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$414.45 | -- | -- |
| 08/10/2018 | Q2 | -- | -- | -$442.50 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$547.50 | -- | -- |
| 03/23/2018 | Q4 | -- | -- | -$1,507.50 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$1,042.50 | -- | -- |
| 08/10/2017 | Q2 | -- | -- | -$1,455.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$2,475.00 | -- | -- |
| 03/23/2017 | Q4 | -- | -- | -$1,800.00 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | -$1,950.00 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$3,225.00 | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -$3,075.00 | -- | -- |
| 03/03/2016 | Q4 | -- | -- | -$2,142.28 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | $1,125.00 | -- | -- |
| 08/06/2015 | Q2 | -- | -- | $3,375.00 | -- | -- |
| 05/11/2015 | Q1 | -- | -- | -$21,238.50 | -- | -- |
| 03/12/2015 | Q4 | -- | -- | -$7,470.33 | -- | -- |
Plus Therapeutics Earnings Questions
-
How Much did Plus Therapeutics Generate in Revenue Last Quarter?
Plus Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Plus Therapeutics Beat Earnings Last Quarter?
Plus Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.56 per share.
-
Is Plus Therapeutics Profitable?
Plus Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Plus Therapeutics EPS Next Year?
Plus Therapeutics's earnings are forecast to decrease from -$4.24 per share to -$4.87 per share next year representing a decrease of -52.99%.
-
When is Plus Therapeutics's Earnings Date?
Currently, Plus Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
